Cargando…
Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections
Several drug screening campaigns identified Calpeptin as a drug candidate against SARS-CoV-2. Initially reported to target the viral main protease (M(pro)), its moderate activity in M(pro) inhibition assays hints at a second target. Indeed, we show that Calpeptin is an extremely potent cysteine cath...
Ejemplares similares
-
Editorial: Emerging human viruses with pandemic potential: Diagnostics, pathogenesis, and therapeutics
por: Botosso, Viviane Fongaro, et al.
Publicado: (2023) -
Hemorrhagic fever viruses: Pathogenesis, therapeutics, and emerging and re-emerging potential
por: Flórez-Álvarez, Lizdany, et al.
Publicado: (2022) -
The Structure of Clostridioides difficile SecA2 ATPase Exposes Regions Responsible for Differential Target Recognition of the SecA1 and SecA2-Dependent Systems
por: Lindič, Nataša, et al.
Publicado: (2020) -
Therapeutic use of calpeptin in COVID-19 infection
por: Inal, Jameel, et al.
Publicado: (2022) -
Targeting SUMOylation in Plasmodium as a Potential Target for Malaria Therapy
por: Sumam de Oliveira, Daffiny, et al.
Publicado: (2021)